AI
Friday, June 21, 2024 12:44:29 PM
"As such injections go mainstream, one wrinkle Galderma could find is competition. The Swiss company is the No. 2 player globally in the segment behind AbbVie, but the rapid growth of the market has attracted new entrants that could erode its market share, analysts at UBS said in a note."
https://www.wsj.com/business/skincare-company-galderma-sees-opportunity-in-ozempic-face-6f2d6738
Recent RVNC News
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
